vs
MADRIGAL PHARMACEUTICALS, INC.（MDGL）与Rapid7, Inc.（RPD）财务数据对比。点击上方公司名可切换其他公司
MADRIGAL PHARMACEUTICALS, INC.的季度营收约是Rapid7, Inc.的1.5倍（$321.1M vs $217.4M），Rapid7, Inc.净利率更高（1.4% vs -18.2%，领先19.7%），MADRIGAL PHARMACEUTICALS, INC.同比增速更快（210.8% vs 0.5%），Rapid7, Inc.自由现金流更多（$36.4M vs $-133.8M）
本公司是一家美国生物制药企业，成立于2002年，专注于研发新型合成胆汁酸类似物，可用于治疗原发性胆汁性胆管炎、非酒精性脂肪肝、肝硬化等慢性肝病，以及胆汁酸性腹泻等肠道疾病。
Rapid7是全球领先的网络安全企业，提供漏洞管理、威胁检测与响应、云安全、安全分析等全系列安全解决方案，服务全球科技、医疗、金融、制造等行业的各类规模企业及公共部门客户，助力客户高效识别、应对和缓解网络安全风险。
MDGL vs RPD — 直观对比
营收规模更大
MDGL
是对方的1.5倍
$217.4M
营收增速更快
MDGL
高出210.2%
0.5%
净利率更高
RPD
高出19.7%
-18.2%
自由现金流更多
RPD
多$170.3M
$-133.8M
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $321.1M | $217.4M |
| 净利润 | $-58.6M | $3.1M |
| 毛利率 | — | 68.9% |
| 营业利润率 | -18.6% | 1.0% |
| 净利率 | -18.2% | 1.4% |
| 营收同比 | 210.8% | 0.5% |
| 净利润同比 | 1.4% | 44.1% |
| 每股收益（稀释后） | $-2.55 | $0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MDGLRPD
| Q4 25 | $321.1M | $217.4M | ||
| Q3 25 | $287.3M | $218.0M | ||
| Q2 25 | $212.8M | $214.2M | ||
| Q1 25 | $137.3M | $210.3M | ||
| Q4 24 | $103.3M | $216.3M | ||
| Q3 24 | $62.2M | $214.7M | ||
| Q2 24 | — | $208.0M | ||
| Q1 24 | $0 | $205.1M |
净利润MDGLRPD
| Q4 25 | $-58.6M | $3.1M | ||
| Q3 25 | $-114.2M | $9.8M | ||
| Q2 25 | $-42.3M | $8.3M | ||
| Q1 25 | $-73.2M | $2.1M | ||
| Q4 24 | $-59.4M | $2.2M | ||
| Q3 24 | $-107.0M | $15.4M | ||
| Q2 24 | — | $6.5M | ||
| Q1 24 | $-147.5M | $1.4M |
毛利率MDGLRPD
| Q4 25 | — | 68.9% | ||
| Q3 25 | — | 70.2% | ||
| Q2 25 | — | 70.6% | ||
| Q1 25 | 96.7% | 71.7% | ||
| Q4 24 | — | 69.5% | ||
| Q3 24 | — | 70.6% | ||
| Q2 24 | — | 70.7% | ||
| Q1 24 | — | 70.3% |
营业利润率MDGLRPD
| Q4 25 | -18.6% | 1.0% | ||
| Q3 25 | -39.7% | 2.7% | ||
| Q2 25 | -22.2% | 1.6% | ||
| Q1 25 | -57.8% | -0.0% | ||
| Q4 24 | -64.8% | 3.4% | ||
| Q3 24 | -187.1% | 6.0% | ||
| Q2 24 | — | 2.5% | ||
| Q1 24 | — | 4.7% |
净利率MDGLRPD
| Q4 25 | -18.2% | 1.4% | ||
| Q3 25 | -39.8% | 4.5% | ||
| Q2 25 | -19.9% | 3.9% | ||
| Q1 25 | -53.4% | 1.0% | ||
| Q4 24 | -57.5% | 1.0% | ||
| Q3 24 | -172.0% | 7.2% | ||
| Q2 24 | — | 3.1% | ||
| Q1 24 | — | 0.7% |
每股收益（稀释后）MDGLRPD
| Q4 25 | $-2.55 | $0.05 | ||
| Q3 25 | $-5.08 | $0.15 | ||
| Q2 25 | $-1.90 | $0.13 | ||
| Q1 25 | $-3.32 | $0.03 | ||
| Q4 24 | $-2.50 | $0.08 | ||
| Q3 24 | $-4.92 | $0.21 | ||
| Q2 24 | — | $0.09 | ||
| Q1 24 | $-7.38 | $0.02 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $198.7M | $474.7M |
| 总债务越低越好 | $339.9M | — |
| 股东权益账面价值 | $602.7M | $154.7M |
| 总资产 | $1.3B | $1.7B |
| 负债/权益比越低杠杆越低 | 0.56× | — |
8季度趋势，按日历期对齐
现金及短期投资MDGLRPD
| Q4 25 | $198.7M | $474.7M | ||
| Q3 25 | $295.7M | $407.1M | ||
| Q2 25 | $186.2M | $511.7M | ||
| Q1 25 | $183.6M | $493.5M | ||
| Q4 24 | $100.0M | $521.7M | ||
| Q3 24 | $232.7M | $443.7M | ||
| Q2 24 | — | $442.6M | ||
| Q1 24 | $622.5M | $411.7M |
总债务MDGLRPD
| Q4 25 | $339.9M | — | ||
| Q3 25 | $339.8M | — | ||
| Q2 25 | $118.4M | — | ||
| Q1 25 | $118.0M | — | ||
| Q4 24 | $117.6M | — | ||
| Q3 24 | $117.1M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $116.1M | — |
股东权益MDGLRPD
| Q4 25 | $602.7M | $154.7M | ||
| Q3 25 | $625.7M | $127.2M | ||
| Q2 25 | $696.0M | $90.4M | ||
| Q1 25 | $710.6M | $52.7M | ||
| Q4 24 | $754.4M | $17.7M | ||
| Q3 24 | $777.2M | $-5.1M | ||
| Q2 24 | — | $-52.6M | ||
| Q1 24 | $850.8M | $-86.4M |
总资产MDGLRPD
| Q4 25 | $1.3B | $1.7B | ||
| Q3 25 | $1.4B | $1.7B | ||
| Q2 25 | $1.0B | $1.6B | ||
| Q1 25 | $996.6M | $1.6B | ||
| Q4 24 | $1.0B | $1.7B | ||
| Q3 24 | $1.1B | $1.6B | ||
| Q2 24 | — | $1.5B | ||
| Q1 24 | $1.1B | $1.5B |
负债/权益比MDGLRPD
| Q4 25 | 0.56× | — | ||
| Q3 25 | 0.54× | — | ||
| Q2 25 | 0.17× | — | ||
| Q1 25 | 0.17× | — | ||
| Q4 24 | 0.16× | — | ||
| Q3 24 | 0.15× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.14× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-133.5M | $37.6M |
| 自由现金流经营现金流 - 资本支出 | $-133.8M | $36.4M |
| 自由现金流率自由现金流/营收 | -41.7% | 16.8% |
| 资本支出强度资本支出/营收 | 0.1% | 0.5% |
| 现金转化率经营现金流/净利润 | — | 12.01× |
| 过去12个月自由现金流最近4个季度 | — | $146.2M |
8季度趋势，按日历期对齐
经营现金流MDGLRPD
| Q4 25 | $-133.5M | $37.6M | ||
| Q3 25 | $79.8M | $39.0M | ||
| Q2 25 | $-47.1M | $47.5M | ||
| Q1 25 | $-88.9M | $29.8M | ||
| Q4 24 | $-104.5M | $63.8M | ||
| Q3 24 | $-67.0M | $44.0M | ||
| Q2 24 | — | $32.9M | ||
| Q1 24 | $-149.2M | $31.1M |
自由现金流MDGLRPD
| Q4 25 | $-133.8M | $36.4M | ||
| Q3 25 | $79.0M | $34.8M | ||
| Q2 25 | — | $46.6M | ||
| Q1 25 | — | $28.4M | ||
| Q4 24 | $-104.7M | $62.6M | ||
| Q3 24 | $-67.8M | $42.6M | ||
| Q2 24 | — | $32.6M | ||
| Q1 24 | $-149.5M | $30.4M |
自由现金流率MDGLRPD
| Q4 25 | -41.7% | 16.8% | ||
| Q3 25 | 27.5% | 16.0% | ||
| Q2 25 | — | 21.8% | ||
| Q1 25 | — | 13.5% | ||
| Q4 24 | -101.3% | 28.9% | ||
| Q3 24 | -109.0% | 19.9% | ||
| Q2 24 | — | 15.7% | ||
| Q1 24 | — | 14.8% |
资本支出强度MDGLRPD
| Q4 25 | 0.1% | 0.5% | ||
| Q3 25 | 0.3% | 1.9% | ||
| Q2 25 | 0.0% | 0.4% | ||
| Q1 25 | 0.0% | 0.6% | ||
| Q4 24 | 0.2% | 0.5% | ||
| Q3 24 | 1.3% | 0.6% | ||
| Q2 24 | — | 0.1% | ||
| Q1 24 | — | 0.3% |
现金转化率MDGLRPD
| Q4 25 | — | 12.01× | ||
| Q3 25 | — | 3.97× | ||
| Q2 25 | — | 5.70× | ||
| Q1 25 | — | 14.14× | ||
| Q4 24 | — | 29.36× | ||
| Q3 24 | — | 2.85× | ||
| Q2 24 | — | 5.03× | ||
| Q1 24 | — | 22.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MDGL
| Rebates Customer Fees Credits Co Pay Assistance And Other | $208.5M | 65% |
| Other | $76.0M | 24% |
| Chargebacks Discounts For Prompt Pay And Other Allowances | $36.6M | 11% |
RPD
| Products | $209.1M | 96% |
| Services | $8.2M | 4% |
